You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic colorectal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Tanta (Sulfasalazine)

Recruiting
  • Metastatic Colorectal Cancer
  • Tanta, El-Gharbia Governorate, Egypt
    Tanta University Hospital
Nov 15, 2023

Metastatic Colorectal Cancer Trial in Tanta (Nitazoxanide)

Recruiting
  • Metastatic Colorectal Cancer
  • Tanta, El-Gharbia Governorate, Egypt
    Tanta University Hospital
Sep 17, 2023

Metastatic Colorectal Cancer Trial in Nanchang (Fruquintinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Nov 1, 2023

Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 3, 2023

Recurrent or Metastatic Colorectal Cancer Trial (Nelmastobart and Capecitabine)

Not yet recruiting
  • Recurrent or Metastatic Colorectal Cancer
  • Nelmastobart and Capecitabine
  • (no location specified)
Aug 6, 2023

Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Oct 31, 2023

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Liposomal irinotecan
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
May 2, 2023

Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • (no location specified)
Nov 1, 2023

Learn More About Order of Different Treatments and Their Effects

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • (no location specified)
Nov 13, 2023

Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab and irinotecan
  • (no location specified)
Jul 26, 2023

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • (no location specified)
Oct 25, 2023

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

Not yet recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Sep 1, 2023

Learn More About Long-Term Responses to Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Whippany, New Jersey
    Bayer
Sep 1, 2023

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal

Completed
  • Colorectal Cancer
  • Fruquintinib combined with anti-PD-1 antibodies
  • ChangSha, Hunan, China
    Hunan Cancer Hospital
Aug 27, 2023

Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Feb 15, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite

Completed
  • Metastatic Colorectal Adenocarcinoma
  • regorafenib plus anti-PD-1 antibodies
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 4, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Couple-Based Mindfulness Intervention for Metastatic Colorectal

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Qualitative interview
  • Cognitive Interviews
  • Aurora, Colorado
    University of Colorado Cancer Center
Apr 21, 2023

Metastatic Colorectal Cancer Trial in Tanta (Silymarin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Tanta, Egypt
    faculty of Pharmacy , Tanta University
Dec 8, 2022

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023